|
|
|
|
Project Title:
|
Review of the Clinical and Translational Science Awards Program at the National Center for Advancing Translational Sciences
|
| PIN:
|
IOM-HSP-12-10
|
Major Unit:
|
Institute of Medicine
|
Sub Unit:
|
Board on Health Sciences Policy
|
RSO:
|
Liverman, Cathy
|
|
|
Subject/Focus Area:
|
Health and Medicine
|
|
Review of the Clinical and Translational Science Awards Program at the National Center for Advancing Translational Sciences
December 12, 2012 - December 13, 2012
National Academy of Sciences Building
2100 C St. NW
Washington D.C.
|
|
If you would like to attend the sessions of this meeting that are open
to the public or need more information please contact:
|
| Contact Name:
Judy Estep
|
| Email:
jestep@nas.edu
|
| Phone:
202-334-2013
|
Fax:
202-334-1329
|
|
Agenda:
Wednesday, December 12, 2012
DRAFT PUBLIC AGENDA
OPEN SESSION: NAS 120
7:30 – 8:00 a.m. Breakfast (available for purchase in NAS cafeteria)
8:00 – 8:05 Welcome and Opening Remarks: Alan Leshner, Chair
8:05 – 8:20 CTSA Overview – Goals of the Program
8:20 – 9:50 Panel 1: Translation of Basic Science to Human Studies: Advancing T1 and T2 Research, Facilitator: Cliff Rosen
8:20 – 8:25 Panel Introductions
8:25 – 8:35 CTSA Perspective: Garret FitzGerald, University of Pennsylvania
8:35 – 8:45 CTSA Perspective: Sundeep Khosla, Mayo Clinic
8:45 – 8:55 Community Perspective: Bernard Ewigman, University of Chicago
8:55 – 9:05 Industry Perspective: Jacqueline B. Fine, Merck Research Laboratories
9:05 – 9:50 Discussion with the Committee
9:50 – 10:00 Break
10:00 – 11:30 Panel 2: Children’s Health Research: Role of the CTSA Program, Facilitator: Meg McCabe and Phyllis Dennery
10:00 – 10:05 Panel Introductions
10:05 – 10:15 CTSA Consortium Child Health Oversight Committee: Jonathan Davis, Tufts University
10:15 – 10:25 CTSA Perspective: Margaret Grey, Yale School of Nursing (via conference call)
10:25 – 10:35 CTSA Perspective: Terence Flotte, University of Massachusetts
10:35 – 10:45 Community Perspective: Susan Weiner, Children’s Cause for Cancer Advocacy
10:45 – 11:30 Discussion with the Committee
11:45 – 12:30 Lunch (available for purchase in NAS cafeteria)
12:30 – 1:45 Panel 3: Collaborations Across CTSAs – Current Status and Future Plans, Facilitator: Sue Curry
12:30 – 12:35 Panel Introductions
12:35 – 12:45 CTSA Collaborating Center (C4) Overview: Gordon Bernard, Vanderbilt University
12:45 – 12:55 Collaborations on Informatics: Paul Harris, Vanderbilt University
12:55 – 1:05 CTSA Perspective: Marc Drezner, University of Wisconsin
1:05 – 1:15 Community Perspective: Mickey Eder, Access Community Health Network, Chicago
1:15 – 1:45 Discussion with the Committee
THURSDAY
1:45 – 3:00 Panel 4: Evaluating the CTSA Program. Facilitator: Robin Kelley
1:45 – 1:50 Panel Introductions
1:50 – 2:00 Westat Evaluations: Joy Frechtling, Westat
2:00 – 2:10 NCATS Request for Information: Josie Briggs, NCATS, NIH
2:10 – 2:20 NCATS/CTSA Integration Working Group: Steve Katz, NIAMS, NIH
2:20 – 2:30 Evaluating Large Scale Programs – Frameworks and Considerations: David Chavis, Community Science
2:30 – 3:00 Discussion with the Committee
3:00 – 3:15 Break
3:15 – 4:45 Panel 5: Roundtable Discussion: Future Directions for the Mission and Goals of the CTSA Program, Facilitator: Sharon Terry
3:15 – 3:20 Roundtable Introductions
3:20 – 4:00 Opening Comments on the CTSA Program
Tachi Yamada, Takeda Pharmaceuticals (via conference call)
Wylie Burke, University of Washington (via conference call)
Other Speakers TBD
4:00– 4:45 Roundtable and Committee Discussion
4:45 – 5:30 Public Testimony – Registered Speakers, Moderator: Alan Leshner
(3 minutes per speaker)
Speakers TBD
5:30 p.m. Adjourn
Thursday, December 13, 2012
CLOSED SESSION
|
Closed Session Summary Posted After the Meeting
The following committee members were present at the closed sessions of the meeting:
Alan Leshner
Sharon Terry
Susan Axelrod
Enriqueta Bond
Ann Bonham
Susan Curry
Phyllis Dennery
Ralph Horwitz
Jeffrey Kahn
Robin Kelley
Margaret McCabe
Edith Perez
Clifford Rosen
The following topics were discussed in the closed sessions:
Day’s Objectives
Workshop Summary and Highlights
SOT and Approach to Fulfilling the Task
Discuss Previous CTSA Evaluations and Reports
Review and Revise the Report Outline
Discuss Areas for Potential Findings and Recommendations
Next Steps
The following materials (written documents) were made available to the committee in the closed sessions:
-Draft of January workshop agenda
-Academy Health’s response to RFI
-Metrics 2.0: Standardizing CTSA Measurement/Measuring Process PowerPoint Slides
-CC-CHOC 2011-2012 Priorities
-NCATS mission, research, and About the CTSA webpages
-Vision, Mission, and Strategic Goals for the CTSA Program and Consortium
-Huskins, W. C., et al. 2012. Tracking the impact of the National Institutes of Health Clinical and Translational Science Awards on child health research: developing and evaluating a measurement strategy. Nature 71(5): 619-623.
-Huskins, W. C. and J. Rainwater. 2012. CTSA Consortium Child Health Oversight Committee Metrics of Success
-PowerPoint presentation given at CTSA Evaluaiton Key Function Committee Face-to-Face Meeting, October 8.
-Briefing Book
Date of posting of Closed Session Summary:
December 18, 2012
|
|
|
